Nirmatrelvir/ritonavir is challenging to prescribe safely because of drug-drug interactions. In this study, an interdisciplinary team was able to prescribe nirmatrelvir/ritonavir safely and feasibly via telemedicine. Providers should be diligent about ascertaining and communicating modifications of concomitant medications to patients.
All Keywords
【저자키워드】 COVID-19, Telemedicine, Paxlovid, Drug interactions, interdisciplinary team,
【저자키워드】 COVID-19, Telemedicine, Paxlovid, Drug interactions, interdisciplinary team,